<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medlit</journal-id><journal-title-group><journal-title xml:lang="ru">Гигиена и санитария</journal-title><trans-title-group xml:lang="en"><trans-title>Hygiene and Sanitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0016-9900</issn><issn pub-type="epub">2412-0650</issn><publisher><publisher-name>Federal Scientific Center of Hygiene named after F.F. Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47470/0016-9900-2017-96-8-734-737</article-id><article-id custom-type="elpub" pub-id-type="custom">medlit-885</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ГИГИЕНА ОКРУЖАЮЩЕЙ СРЕДЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ENVIRONMENTAL HYGIENE</subject></subj-group></article-categories><title-group><article-title>Пирогенные соединения в пыли жилых помещений г. Москвы</article-title><trans-title-group xml:lang="en"><trans-title>Pyrogenic compounds in house dust of Moscow dwellings</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ахапкина</surname><given-names>Ирина Гавриловна</given-names></name><name name-style="western" xml:lang="en"><surname>Akhapkina</surname><given-names>Irina G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Вед. науч. сотр., канд. биол. наук, ФГБНУ Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова, 105064, г. Москва.</p><p>e-mail: isun17@yandex.ru</p></bio><bio xml:lang="en"><p>Scientist researcher, MD, PhD., I.I. Mechnikov Research Institute of Vaccines and Sera, Moscow, 105064, Russian Federation.</p><p>e-mail: isun17@yandex.ru</p></bio><email xlink:type="simple">isun17@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Антропова</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Antropova</surname><given-names>A. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Желтикова</surname><given-names>Т. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Zheltikova</surname><given-names>T. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова»</institution></aff><aff xml:lang="en"><institution>I.I. Mechnikov Research Institute of Vaccines and Sera</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>21</day><month>10</month><year>2020</year></pub-date><volume>96</volume><issue>8</issue><fpage>734</fpage><lpage>737</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ахапкина И.Г., Антропова А.Б., Желтикова Т.М., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Ахапкина И.Г., Антропова А.Б., Желтикова Т.М.</copyright-holder><copyright-holder xml:lang="en">Akhapkina I.G., Antropova A.B., Zheltikova T.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rjhas.ru/jour/article/view/885">https://www.rjhas.ru/jour/article/view/885</self-uri><abstract><p>Экспозиция пирогенных соединений является важной характеристикой помещений. Это важно для людей с сенсибилизацией, особенно к аэроаллергенам. Цель работы — изучение экспозиции липополисахаридов (ЛПС) и бета-глюканов в пыли жилых помещений Москвы. Концентрацию ЛПС определяли с помощью гель-тромб-теста. Для определения содержания бета-глюканов использовали тест-набор «Glucatell» и новый ингибиторный иммуноферментный метод, позволяющий выявлять в основном линейные бета-глюканы и их фрагменты. Метод основан на использовании поликлональной кроличьей антисыворотки, полученной против конъюгата нона-β-(1→3)-D-глюкозида с бычьим сывороточным альбумином, а в качестве ингибиторного агента используется нона-β-(1→3)-D-глюкозид. Концентрация ЛПС варьировала от 0,6 до 6 мкг на 1г пыли (далее мкг/г), среднее значение концентрации равнялось 2,19 ± 1,74 мкг/г (Ме = 1,2 мкг/г). Концентрация бета-глюканов в Glucatell-тесте варьировала от 8 до 116 мкг/г, среднее значение концентрации составляло 75,58 ± 25,27 мкг/г (Ме = 77 мкг/г), концентрация бета-глюканов при иммуноферментном определении варьировала от 10 до 109 мкг/г, среднее значение содержания составляло 28,45 ± 14,12 мкг/г (Ме = 24 мкг/г). Экспозиция ЛПС не превышала 1,2 мкг/г в 65% квартир. Такие концентрации ЛПС в окружающей среде сенсибилизированных людей могут стимулировать развитие аллергических реакций. Отмечена тенденция к определению более высокой экспозиции бета-глюканов при помощи тест-набора «Glucatell», которая составляла от 40 до 100 мкг/г в 76% квартир, при использовании иммуноферментного метода в 84% квартир содержание бета-глюканов составляло от 11 до 40 мкг/г. Корреляция между данными, полученными разными методами, отсутствовала (r = 0,2056, p &lt; 0,05).</p><p>Таким образом, разные методы позволяют определять пирогенные соединения разного строения. Следовательно, данные показатели являются самостоятельными характеристиками пирогенности среды, и определение концентрации каждого из них в одном помещении представляется целесообразным.</p></abstract><trans-abstract xml:lang="en"><p>Exposure to pyrogenic compounds are essential characteristics of dwellings. This is important for people with sensitization, especially to airborne allergens. The aim of this work was to study the exposure of LPS and beta-glucans in house dust of Moscow dwellings. The determination of the LPS concentration was implemented with the use of LAL-test. The content of beta-glucans was determined with the use both of the “Glucatell”-test and the new inhibitor immunoassay method, which allows identify generally linear beta-glucans and their fragments. The method is based on the use of polyclonal rabbit antiserum obtained against the conjugate nona-β-(1→3)-D-glucoside with bovine serum albumin, and the inhibitory agent is nona-β-(1→3)-D-glucoside. The LPS concentration varied from 0.6 to 6 µg/g dust, mean concentration was equal to 2.19±1.74 µg/g dust (M=1.2 µg/g dust). The concentration of beta-glucans in “Glucatell”-test ranged from 8 to 116 µg /g dust, mean concentration was 75.58±25.27 µg/g dust (M=77 µg/g of dust), the concentration of beta-glucans in ILISA ranged from 10 to 109 µg/g dust, mean content was of 28.45±14.12 µg/g dust (M=24 µg/g dust). LPS exposure did not exceed 1.2 µg/g of dust in 65% of the apartments. Such concentrations of LPS in the environment of sensitized people can stimulate the development of allergic reactions. There was a trend in the detection of higher exposure of beta-glucans by using “Glucatell” test, which ranged from 40 to 100 µg/g of dust in 76% of the apartments when using the ILISA in 84% of the apartments in the content of beta-glucans ranged from 11 to 40 µg/g of dust. The correlation between data obtained by different methods was absent (r=0.2056, p&lt;0.05). Thus, the different methods allow determine pyrogenic compounds of different structure. Therefore, these indices are independent of the characteristics of pyrogenic environment. The determination of the concentration of each of them in the same room seems to be reasonable.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ЛПС</kwd><kwd>бета-глюканы</kwd><kwd>линейные бета-глюканы</kwd><kwd>домашняя пыль</kwd><kwd>иммуноферментный анализ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>lipopolysaccharide</kwd><kwd>beta-glucans</kwd><kwd>linear beta-glucans</kwd><kwd>house dust</kwd><kwd>ELISA</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Netea M.G., Brown G.D., Kullberg B.J., Gow N.A. An integrate model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Microbiol. 2008; (6): 67-78.</mixed-citation><mixed-citation xml:lang="en">Netea M.G., Brown G.D., Kullberg B.J., Gow N.A. An integrate model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Microbiol. 2008; (6): 67–78.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Mantovani M.S., Bellini M.F., Angeli J.P.F., Oliveira R.J., Silva A.F., Ribeiro L.R. et al. β-Glucans in promoting health: Prevention against mutation and cancer. Mutat. Res. 2008; 658 (3): 154-61.</mixed-citation><mixed-citation xml:lang="en">Mantovani M.S., Bellini M.F., Angeli J.P.F., Oliveira R.J., Silva A.F., Ribeiro L.R. et al. β-Glucans in promoting health: Prevention against mutation and cancer. Mutat. Res. 2008; 658 (3): 154–61.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Young Shih-Houng, Wolfarth M.G., Roberts J.R., Kashon M.L., Antonini J.M. Adjuvant effect of zymosan after pulmonary treatment in a mouse ovalbumin allergy model. Exp. Lung Res. 2013; 39 (1): 48-57.</mixed-citation><mixed-citation xml:lang="en">Young Shih-Houng, Wolfarth M.G., Roberts J.R., Kashon M.L., Antonini J.M. Adjuvant effect of zymosan after pulmonary treatment in a mouse ovalbumin allergy model. Exp. Lung Res. 2013; 39 (1): 48–57.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Schram-Bijkerk D., Doekes G., Douwes J., Boeve M., Riedler J., Ublagger E. et al. Bacterial and fungal agents in house dust and wheeze in children: the PARSIFAL study. Clin. Exp. Allergy. 2005; 35: 1272-8.</mixed-citation><mixed-citation xml:lang="en">Schram-Bijkerk D., Doekes G., Douwes J., Boeve M., Riedler J., Ublagger E. et al. Bacterial and fungal agents in house dust and wheeze in children: the PARSIFAL study. Clin. Exp. Allergy. 2005; 35: 1272–8.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Eldridge M., Peden D. Allergen challenge enhance LPS-induced nasal inflammation. J. Allergy Clin. Immunol. 2000; 105 (1-2): 81.</mixed-citation><mixed-citation xml:lang="en">Eldridge M., Peden D. Allergen challenge enhance LPS-induced nasal inflammation. J. Allergy Clin. Immunol. 2000; 105 (1-2): 81.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Eisenbarth S.C., Piggott D.A., Huleatt J.W., Visintin I., Herrick C.A., Bottomly K. Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exper. Med. 2002; 196 (12): 1645-51.</mixed-citation><mixed-citation xml:lang="en">Eisenbarth S.C., Piggott D.A., Huleatt J.W., Visintin I., Herrick C.A., Bottomly K. Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exper. Med. 2002; 196 (12): 1645–51.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zekovic D.B., Kwiatkowski S., Vrvic M.M., Jakovljević D., Moran C.A. Natural modified (1→3)-b-glucans in health promotion and disease alleviation. Crit. Rev. Biotechnol. 2005; 25(4): 205-30.</mixed-citation><mixed-citation xml:lang="en">Zekovic D.B., Kwiatkowski S., Vrvic M.M., Jakovljević D., Moran C.A. Natural modified (1→3)-b-glucans in health promotion and disease alleviation. Crit. Rev. Biotechnol. 2005; 25(4): 205–30.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Беседнова Н.Н., Иванушко Л.А., Звягинцева Т.Н., Елякова Л.А. Иммунотропные свойства 1,3/1,6-β-D-глюканов. Антибиотики и химиотерапия. 2000; (2): 37-44.</mixed-citation><mixed-citation xml:lang="en">Besednova N.N., Ivanushko L.A., Zvyagintseva T.N., Elyakova L.A. Immunotropnie svoistva 1,3/1,6-β-D-glyukanov. Antibiotiki i khimioterapiya. 2000; (2): 37–44. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ахапкина И.Г., Желтикова-Вострокнутова Т.М., Антропова А.Б., Егорова О.В., Калинкина М.А., Яшунский Д.В. и др. Иммуноферментная тест-система для количественного определения микополисахаридов и их производных в пыли окружающей среды. Патент РФ № 2543323; 2015.</mixed-citation><mixed-citation xml:lang="en">Akhapkina I.G., Zheltikova-Vostroknutova T.M., Antropova A.B., Egorova O.V., Kalinkina M.A., Yashunskiy D.V. et al. Immunoenzyme test system for the quantitative determination of mycopolysaccharides and their derivatives in environmental dust. Patent RF № 2543323; 2015. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ахапкина И.Г., Желтикова Т.М., Антропова А.Б., Михайлова Н.А., Яшунский Д.В., Карелин А.А. и др. Разработка методических подходов к созданию реагентов для иммуноферментного определения линейных β-(1→3)-глюканов и их производных в окружающей среде. Иммунология. 2015; 36 (5): 276-9.</mixed-citation><mixed-citation xml:lang="en">Akhapkina I.G., Zheltikova T.M., Antropova A.B., Mikhaylova N.A., Yashunskiy D.V., Karelin A.A., et al. Razrabotka metodicheskih podhodov k sozdaniju reagentov dlja immunofermentnogo opredelenija linejnyh β-(1→3)-gljukanov i ih proizvodnyh v okruzhajushhej srede. Immunologiya. 2015; 36 (5): 276–9. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Brooks C.R., Siebers R., Crane J., Noss I., Wouters I.M., Sander I., et al. Measurement of β-(1,3)-glucan in household dust samples using Limulus amebocyte assay and enzyme immunoassays: an inter-laboratory comparison. Environ. Sci. Process Impacts. 2013; 15 (2): 405-11</mixed-citation><mixed-citation xml:lang="en">Brooks C.R., Siebers R., Crane J., Noss I., Wouters I.M., Sander I., et al. Measurement of β-(1,3)-glucan in household dust samples using Limulus amebocyte assay and enzyme immunoassays: an inter-laboratory comparison. Environ. Sci. Process Impacts. 2013; 15 (2): 405–11.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ахапкина И.Г., Антропова А.Б., Ахматов Э.А., Желтикова Т.М. Индукция синтеза цитокинов синтетическим фрагментом линейного (1-3)-бета-глюкана в опытах in vitro. В кн.: Материалы III международного микологического форума «Успехи медицинской микологии». Том 14. М.: Национальная академия микологии; 2015: 381-3</mixed-citation><mixed-citation xml:lang="en">Akhapkina I.G., Antropova A.B., Akhmatov E.A., Zheltikova T.M. Induction of cytokine synthesis by a synthetic fragment of linear (1-3) beta-glucan in in vitro experiments. In: Materials of the III International Mycological Forum «The success of medical mycology». Volume 14 [Materialy III mezhdunarodnogo mikologicheskogo foruma «Uspekhi meditsinskoy mikologii». Tom 14]. Moscow: Natsional’naya akademiya mikologii; 2015: 381–3. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Engstad C.S., Engstad R.E., Olsen J.O., Osterud B. The effect of soluble beta-1,3-glucan and lipopolysaccharide on cytokine production and coagulation activation in whole blood. Int. Immunopharmacol. 2002; 2 (11): 1585-97</mixed-citation><mixed-citation xml:lang="en">Engstad C.S., Engstad R.E., Olsen J.O., Osterud B. The effect of soluble beta-1,3-glucan and lipopolysaccharide on cytokine production and coagulation activation in whole blood. Int. Immunopharmacol. 2002; 2 (11): 1585–97.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
